Works matching IS 02770008 AND DT 2022 AND VI 42 AND IP 7

Results: 9

Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients.

Published in:

Pharmacotherapy, 2022, v. 42, n. 7, p. 580, doi. 10.1002/phar.2710

By:

Doligalski, Christina Teeter;
McKinzie, Cameron J.;
Yang, Anita;
Lobo, L. Jason;
Coakley, Raymond

Publication type:

Article

Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with COVID‐19: A retrospective cohort analysis from 28 U.S. Hospitals.

Published in:

Pharmacotherapy, 2022, v. 42, n. 7, p. 529, doi. 10.1002/phar.2709

By:

Harthan, Aaron A.;
Nadiger, Meghana;
McGarvey, Jeremy S.;
Hanson, Keith;
Gharpure, Varsha P.;
Bjornstad, Erica C.;
Chiotos, Kathleen;
Miller, Aaron S.;
Reikoff, Ronald A.;
Gajic, Ognjen;
Kumar, Vishakha;
Walkey, Allan J.;
Kashyap, Rahul;
Tripathi, Sandeep

Publication type:

Article

Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study).

Published in:

Pharmacotherapy, 2022, v. 42, n. 7, p. 540, doi. 10.1002/phar.2708

By:

Munger, Mark A.;
Nelson, Scott D.;
Teng, Chia‐Chen;
Cheung, Alfred K.;
Sauer, Brian C.

Publication type:

Article

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review.

Published in:

Pharmacotherapy, 2022, v. 42, n. 7, p. 567, doi. 10.1002/phar.2707

By:

Moore, Thomas J.;
Alami, Abdallah;
Alexander, G. Caleb;
Mattison, Donald R.

Publication type:

Article

Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling.

Published in:

Pharmacotherapy, 2022, v. 42, n. 7, p. 518, doi. 10.1002/phar.2705

By:

Paranjpe, Rutugandha;
Johnson, Michael L.;
Chen, Hua;
Birtcher, Kim;
Serna, Omar;
Mohan, Anjana;
Abughosh, Susan

Publication type:

Article

Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review.

Published in:

Pharmacotherapy, 2022, v. 42, n. 7, p. 549, doi. 10.1002/phar.2704

By:

Babidhan, Riyan;
Lewis, Abigale;
Atkins, Cailin;
Jozefczyk, Nicolas J.;
Nemecek, Branden D.;
Montepara, Courtney A.;
Gionfriddo, Michael R.;
Zimmerman, David E.;
Covvey, Jordan R.;
Guarascio, Anthony J.

Publication type:

Article

Corrigendum.

Published in:: 2022
Publication type:: Correction Notice

Issue Information.

Published in:: Pharmacotherapy, 2022, v. 42, n. 7, p. 515, doi. 10.1002/phar.2421
Publication type:: Article

Myocardial infarction associated with erenumab: A case report.

Published in:

Pharmacotherapy, 2022, v. 42, n. 7, p. 585, doi. 10.1002/phar.2706

By:

Perino, Justine;
Corand, Virginie;
Laurent, Elise;
Théophile, Hélène;
Miremont‐Salamé, Ghada;
Pariente, Antoine;
Colas, Jean‐Laurent;
Couffinhal, Thierry;
Salvo, Francesco

Publication type:

Article